Skip to main content

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heidelberger, C., Chaudhuri, N., Danneburg, P., et al. Fluorinated pyrimidines, a new class of tumor-inhibitory compounds. Nature 179: 663, 1957.

    Article  PubMed  CAS  Google Scholar 

  2. Bosch, L., Harbers, E., and Heidelberger, C. Studies on fluorinated pyrimidines. V. Effects on nucleic acid metabolism in vitro. Cancer Res 18: 335, 1958.

    CAS  Google Scholar 

  3. Harbers, E., Chaudhuri, N., and Heidelberger, C. Studies on fluorinated pyrimidines. VIII. Further biochemical and metabolic investigations. J Biol Chem 234: 1255, 1959.

    PubMed  CAS  Google Scholar 

  4. Burchenal, J. The effects of halogenated pyrimidine derivatives on a spectrum of transplanted mouse leukemias. Proc Amer Assoc Cancer Res 2: 285, 1958.

    Google Scholar 

  5. Curreri, A., Ansfield, F., McIver, F., et al. Clinical studies with 5-fluorouracil. Cancer Res 18: 478, 1958.

    PubMed  CAS  Google Scholar 

  6. Gold, G., Hall, T., Shnider, B., et al. A clinical study of 5-fluorouracil. Cancer Res 19: 935, 1959.

    PubMed  CAS  Google Scholar 

  7. Olson, K., and Greene, J. Evaluation of 5-fluorouracil in treatment of cancer. J Nat Cancer Instit 25: 133, 1960.

    CAS  Google Scholar 

  8. Lemon, H. Reduction of 5-fluorouracil toxicity in man with retention of anticancer effect by prolonged intravenous administration in 5% dextrose. Cancer Chemother Rep 8: 97, 1960.

    PubMed  CAS  Google Scholar 

  9. Wilson, W. Chemotherapy of human solid tumors with 5fluorouracil. Cancer 13: 1230, 1960.

    Article  PubMed  CAS  Google Scholar 

  10. Young, C., Ellison, R., Sullivan, R., et al. The clinical evaluation of 5-fluorouracil and 5-fluoro-2’-deoxyuridine in solid tumors in adults. A progress report. Cancer Chemother Rep 6: 17, 1960.

    PubMed  CAS  Google Scholar 

  11. Allaire, F., Thieme, E., and Korst, D. Cancer chemotherapy with 5-fluorouràcil alone and in combination with x-ray therapy. Cancer Chemother Rep 14: 59, 1960.

    Google Scholar 

  12. Cornell, G., Cahow, C., Frey, C., et al. Clinical experience with 5-fluorouracil in the treatment of malignant disease. Cancer Chemother Rep 9: 23, 1960.

    PubMed  CAS  Google Scholar 

  13. Krivit, W., and Bentley, H. Use of 5-fluorouracil in the management of advanced malignancies in childhood. Am J Dis Childh 100: 217, 1960.

    CAS  Google Scholar 

  14. Kennedy, B., and Theologides, A. The role of 5-fluorouracil in malignant disease. Ann Intern Med 55: 719, 1961.

    PubMed  CAS  Google Scholar 

  15. Weiss, A., Jackson, L., and Carabasi, R. An evaluation of 5-fluorouracil in malignant disease. Ann Intern Med 55: 731, 1961.

    PubMed  CAS  Google Scholar 

  16. Knoepp, L., Kastl, W., Rayburn, A., et al. Clinical experience with 5-fluorouracil. Cancer Chemother Rep 12: 89, 1961.

    PubMed  CAS  Google Scholar 

  17. Staley, C., Keith, J., Cortes, N., et al. Treatment of advanced cancer with 5-fluorouracil. Surg Gyn and Obstet 112: 185, 1961.

    Google Scholar 

  18. Vaitkevicius, V., Brennan, M., Beckett, V., et al. Clinical evaluation of cancer chemotherapy with 5-fluorouracil. Cancer 41: 131, 1961.

    Article  Google Scholar 

  19. Hurley, J., Ellison, E., and Carey, L. Treatment of advanced cancer of the gastrointestinal tract with antitumor agents. Gastroenterology 41: 557, 1961.

    PubMed  CAS  Google Scholar 

  20. Hurley, J. Chemotherapy of colon tumors: panel discussion. (Cole, W.H., moderator). Am J Surg 103: 94, 1962.

    Article  Google Scholar 

  21. Ansfield, F., Schroeder, J., and Curreri, A. Five years’ clinical experience with 5-fluorouracil. JAMA 181: 295, 1962.

    Article  PubMed  CAS  Google Scholar 

  22. Ellison, R. Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract. N Y J Med 14: 2364, 1962.

    Google Scholar 

  23. Hyman, G., Ultmann, J., and Habif, D. Factors to be considered in the clinical evaluation of a new chemotherapeutic agent (5-fluorouracil). Cancer Chemother Rep 16: 397, 1962.

    PubMed  CAS  Google Scholar 

  24. Curreri, A., and Ansfield, F. Comparison of 5-fluorouracil and 5-fluoro-2’-deoxyuridine in the treatment of far-advanced breast and colon lesions. Cancer Chemother Rep 16: 387, 1962.

    PubMed  CAS  Google Scholar 

  25. Hall, B., and Good, J. Treatment of far-advanced cancer with 5-fluorouracil, used alone and in combination with irradiation. Incidence and duration of remission and survival-time data in 223 patients. Cancer Chemother Rep 16: 369, 1962.

    PubMed  CAS  Google Scholar 

  26. Eyerly, R. The effects of 5-fluorouracil in patients with incurable cancer. Cancer Chemother Rep 20: 89, 1962.

    PubMed  CAS  Google Scholar 

  27. Choy, D., Stylianou, S., and Hangul, A. Experience with 5fluorouracil in a variety of solid tumors. Cancer Chemother Rep 24: 99, 1962.

    PubMed  CAS  Google Scholar 

  28. White, J., Ricketts, W., and Strudwick, W. A clinical study of 5-fluorouracil in a variety of far-advanced human malignancies. J Nat Med Assoc 54: 315, 1962.

    CAS  Google Scholar 

  29. Baines, C., and Ley, D. A preliminary report on the use of 5-fluorouracil in malignant disease. Canad Med Assoc J 86: 207, 1962.

    PubMed  CAS  Google Scholar 

  30. Field, J. 5-fluorouracil treatment of advanced cancer in ambulatory patients. Cancer Chemother Rep 33: 45, 1963.

    PubMed  CAS  Google Scholar 

  31. Dao, T., and Grinberg, R. Fluorinated pyrimidines in treatment of breast cancer patients with liver metastases. Cancer Chemother Rep 27: 71, 1963.

    PubMed  CAS  Google Scholar 

  32. Glenn, J., Hunt, L., and Lathem, J. Chemotherapy of bladder carcinoma with 5-fluorouracil. Cancer Chemother Rep 27: 67, 1963.

    PubMed  CAS  Google Scholar 

  33. Hartmann, J., Origenes, M., Murphy, M., et al. Effects of 2’-deoxy-5-fluorouridine and 5-fluorouracil on childhood leukemia. Cancer Chemother Rep 34: 51, 1964.

    PubMed  CAS  Google Scholar 

  34. Moertel, C., Reitemeier, R., and Hahn, R. Fluorinated pyrimidine therapy of advanced gastrointestinal cancer. Gastroenterology 46: 371, 1964.

    PubMed  CAS  Google Scholar 

  35. Ansfield, F. A less toxic fluorouracil dosage schedule. JAMA 190: 234, 1964.

    Article  Google Scholar 

  36. Talley, R., Vaitkevicius, V., and Leighton, G. Comparison of cyclophosphamide and 5-fluorouracil in the treatment of patients with metastatic breast cancer. Clin Pharm Ther 6: 740, 1965.

    CAS  Google Scholar 

  37. Rochlin, D., Smart, C., and Silva, A. Chemotherapy of malignancies of the gastrointestinal tract. Am J Surg 109: 43, 1965.

    Article  PubMed  CAS  Google Scholar 

  38. Cressy, N., and Schell, H. 5-fluorouracil in glucose and saline: therapeutic effect and toxicity. Cancer Chemother Rep 9: 683, 1966.

    Google Scholar 

  39. Blokhina, N., and Blokhin, N. 5-fluorouracil therapy for cancer of the stomach. Cancer 20: 668, 1967.

    Article  PubMed  CAS  Google Scholar 

  40. Eastern Cooperative Group in Solid Tumor Chemotherapy. Comparison of antimetabolites in the treatment of breast and colon cancer. JAMA 200: 770, 1967.

    Article  Google Scholar 

  41. Horton, J., Gehrt, P., Cunningham, T., et al. A comparison of combination and single drug chemotherapy in cancer of the colon, breast, and other organs. Proc Amer Assoc Cancer Res 8: 120, 1967.

    Google Scholar 

  42. Mackman, S., Ramirez, G., and Ansfield, F. Results of 5fluorouracil given by the multiple daily dose method in disseminated breast cancer. Cancer Chemother Rep 51: 483, 1967.

    Google Scholar 

  43. Moore, G., Bross, I., Ausman, R., et al. Effects of 5fluorouracil (NSC 19893) in 389 patients with cancer. Cancer Chemother Rep 52: 641, 1968.

    PubMed  CAS  Google Scholar 

  44. Malkasian, G., Decker, D., Mussey, E., et al. Observations on gynecologic malignancy treated with 5-fluorouracil. Am J Ob Gyn 100: 1012, 1968.

    Google Scholar 

  45. Jacobs, E., Luce, J., and Wood, D. Treatment of cancer with weekly intravenous 5-fluorouracil. Cancer 22: 1233, 1968.

    Article  PubMed  CAS  Google Scholar 

  46. Ansfield, F., Ramirez, G., Mackman, S., et al. A ten-year study of 5-fluorouracil in disseminated breast cancer with clinical results and survival times. Cancer Res 29: 1062, 1969.

    PubMed  CAS  Google Scholar 

  47. Moertel, C., Reitemeier, R., and Hahn, R. Comparative response of carcinoma of the rectum and carcinoma of the colon to fluorinated pyrimidine therapy. Cancer Chemother Rep 53: 283, 1969.

    PubMed  CAS  Google Scholar 

  48. Hall, T., Cavins, J., Khung, C., et al. Time and vehicle studies of a safe and effective method for administration of 5-fluorouracil. Cancer 19: 1008, 1966.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1970 IFI/Plenum · New York-Washington-London

About this chapter

Cite this chapter

Livingston, R.B., Carter, S.K. (1970). 5-Fluorouracil. In: Single Agents in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1378-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1378-6_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1380-9

  • Online ISBN: 978-1-4684-1378-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics